The global spectrometry market size is expected to reach USD 24.5 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.2% from 2021 to 2028. Key players offer technologically advanced spectrometry products for several healthcare applications and have collaborated with research institutes to develop novel products.
The market is expected to show potential growth in the coming future owing to the introduction of healthcare services using MALDI-TOF mass spectrometry (MS) by key players operating in the market. For instance, in November 2020, Shimadzu Corporation launched the Amyloid MS service for the early diagnosis of amyloid-positive patients in the U.S. The analysis of blood is performed using a combination of MALDI-TOF MS (IP-MS) and immunoprecipitation.
Furthermore, spectrometers are widely used in drug discovery and research and development to study Drug Metabolism and Pharmacokinetics (DMPK) profiles and to study Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) properties of new molecular entities. Hence, the application of spectrometry in drug development is anticipated to show potential growth during the forecast period.
Request a free sample copy or view report summary: Spectrometry Market Report
The Mass Spectrometry (MS) segment is anticipated to witness the fastest CAGR during the forecast period owing to continuous advancements in the technology
The MALDI-TOF MS is a major contributor to the high growth of the MS segment, owing to the introduction of new accessories for MALDI-TOF MS which expands the application range of this technology
The instrument segment dominated the market in 2020. The key players offering extensive instruments for specialized application contribute to the large segment share
Although the availability of various spectrometers is high, many research entities are unable to adopt them owing to a high cost of systems and lack of skilled professionals
Therefore, research entities approach organizations that offer spectroscopy services, which, in turn, is expected to drive the services segment over the forecast period
Pharmaceutical analysis occupied a major portion of the revenue generated by the application segment as spectrometer is commonly used in the quality assurance and quality control departments of pharmaceutical companies
Additionally, ongoing innovation in the technology specialized for pharmaceutical application contributes to the fastest growth of the segment
The government and academic institutions segment generated the largest revenue in 2020 as researchers from various government and academic institutions are engaged in several research studies based on spectroscopy
For instance, the National Institute of Environmental Health Sciences has a support group named The NIEHS Mass Spectrometry Research and Support Group which helps the researchers by providing a broad range of MS analyses
In Asia Pacific, the market is expected to register a lucrative growth rate throughout the forecast period owing to the initiatives taken by various organizations and associations to train and educate young scientists in this region
These bodies also organize conferences to exhibit the latest MS research from the Asian region and to educate the young scientist through assemblies and the Young Scientist Forum
For instance, in January 2020, the mass spectrometry societies in Oceania and the Asian region organized Asia-Oceania Mass Spectrometry Conference (AOMSC) in Macau to showcase the applications and fundamentals of MS
Major market participants such as Thermo Fisher Scientific, Inc., Agilent Technologies, Waters Corporation, and Shimadzu Corporation, have undertaken strategic initiatives to strengthen their position in the market
For instance, in November 2020, Waters Corporation launched RADIAN ASAP System, a new direct mass detector intended for non-MS. This new system can perform accurate and fast analysis of liquids and solids with minimum sample prep. Additionally, the RADIAN ASAP system has applications in pharmaceuticals, forensics, academia, and chemicals and materials
Grand View Research has segmented the global spectrometry market on the basis of type, product, application, end-use, and region:
Spectrometry Type Outlook (Revenue, USD Million, 2017 - 2028)
Molecular Spectrometry
Visible and Ultraviolet Spectroscopy
Infrared Spectroscopy
Nuclear Magnetic Resonance (NMR)
Others
Mass Spectrometry (MS)
MALDI-TOF
Triple Quadrupole
Quadrupole-Trap
Hybrid Linear Ion Trap Orbitrap
Quadrupole-Orbitrap
Atomic Spectrometry
Atomic Absorption Spectroscopy (AAS)
Atomic Emission Spectroscopy (AES)
Atomic Fluorescence Spectroscopy (AFS)
X-ray Fluorescence (XRF)
Inorganic Mass Spectroscopy
Spectrometry Product Outlook (Revenue, USD Million, 2017 - 2028)
Instrument
Consumables
Services
Spectrometry Application Outlook (Revenue, USD Million, 2017 - 2028)
Proteomics
Metabolomics
Pharmaceutical Analysis
Forensic Analysis
Others
Spectrometry End-use Outlook (Revenue, USD Million, 2017 - 2028)
Government & Academic Institutions
Pharmaceutical & Biotechnology Companies
Others
Spectrometry Regional Outlook (Revenue, USD Million, 2017 - 2028)
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Asia Pacific
China
Japan
India
Latin America
Brazil
Mexico
Middle East & Africa (MEA)
South Africa
UAE
List of Key Players of Spectrometry Market
Thermo Fisher Scientific, Inc.
PerkinElmer, Inc.
Agilent Technologies
Waters Corporation
Shimadzu Corporation
Bruker Corporation
JEOL Ltd.
FLIR Systems, Inc.
Endress+Hauser Group
MKS Instruments, Inc.
"The quality of research they have done for us has been excellent..."